Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Melanoma & Soft Tissue Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Safety Medicine & Life Sciences
Riluzole Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Ligands Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2020

Neoplasms
Clinical Trials
Therapeutics
Systems Biology
Pharmacogenetics

Research Output 2003 2019

  • 2551 Citations
  • 22 h-Index
  • 51 Article
  • 7 Review article
  • 2 Chapter
  • 2 Comment/debate
1 Citation (Scopus)

Avelumab in patients with previously treated metastatic melanoma: Phase 1b results from the JAVELIN Solid Tumor trial

Keilholz, U., Mehnert, J., Bauer, S., Bourgeois, H., Patel, M. R., Gravenor, D., Nemunaitis, J. J., Taylor, M. H., Wyrwicz, L., Lee, K. W., Kasturi, V., Chin, K., Von Heydebreck, A. & Gulley, J. L., Jan 16 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 12.

Rutgers, The State University

Research output: Contribution to journalArticle

Melanoma
Neoplasms
Therapeutics
Disease-Free Survival
Survival

Clinical characterization of colitis arising from anti-PD-1 based therapy

Wang, D. Y., Mooradian, M. J., Kim, D. W., Shah, N. J., Fenton, S. E., Conry, R. M., Mehta, R., Silk, A., Zhou, A., Compton, M. L., Al-Rohil, R. N., Lee, S., Voorhees, A. L., Ha, L., McKee, S., Norrell, J. T., Mehnert, J., Puzanov, I., Sosman, J. A., Chandra, S. & 5 others, Gibney, G. T., Rapisuwon, S., Eroglu, Z., Sullivan, R. & Johnson, D. B., Jan 2 2019, In : OncoImmunology. 8, 1, e1524695.

Rutgers, The State University

Research output: Contribution to journalArticle

Colitis
Steroids
Therapeutics
Prednisone
Melanoma
1 Citation (Scopus)

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma

D’Angelo, S. P., Hunger, M., Brohl, A. S., Nghiem, P., Bhatia, S., Hamid, O., Mehnert, J., Terheyden, P., Shih, K. C., Brownell, I., Lebbé, C., Lewis, K. D., Linette, G. P., Milella, M., Schlichting, M., Hennessy, M. H. & Bharmal, M., Apr 2 2019, In : Cancer Immunology, Immunotherapy. 68, 4, p. 609-618 10 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Merkel Cell Carcinoma
Survival
Confidence Intervals
Therapeutics
Proportional Hazards Models